# US 2020/0347365 A1 · Ketoreductase polypeptides for the synthesis of chiral compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0347365 A1
- Document ID: US20200347365A1
- Status: Published application
- Kind: A1
- Application number: 16/874,574
- Filed: 2020-05-14
- Published: 2020-11-05
- Earliest claimed: 2015-02-10
- Assignees: Codexis, Inc.
- Applicants: Codexis, Inc.
- Inventors: Oscar Alvizo; Nicholas J. Agard; Xinkai Xie; David Entwistle; Birgit Kosjek
- Web page: https://patentgrep.com/patent/US20200347365A1

## CPC

- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12P 7/02: containing a hydroxy group
- C12P 7/40: containing a carboxyl group {including Peroxycarboxylic acids}
- C12P 17/12: containing a six-membered hetero ring
- C12P 41/002: {by oxidation/reduction reactions}
- C12Y 101/01184: Carbonyl reductase (NADPH) (1.1.1.184)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize a variety of chiral compounds.

## Claims

### Claim 1

An engineered polynucleotide encoding an engineered polypeptide comprising an amino acid sequence with at least 90% sequence identity to SEQ ID NO:4 and an arginine or lysine at position X249 as compared to SEQ ID NO:4, and wherein said polypeptide has ketoreductase activity with at least 2-fold greater selectivity to the chiral compound 2a relative to chiral compound 2c as compared to SEQ ID NO:4.

### Claim 2 (depends on 1)

The engineered polynucleotide encoding the engineered polypeptide of claim 1, wherein said amino acid sequence further comprises at least one of the following:
the residue corresponding to X68 is a non-polar, or aliphatic residue;
the residue corresponding to X102 is an acidic residue;
the residue corresponding to X110 is an acidic, or aromatic residue;
the residue corresponding to X114 is a non-polar residue;
the residue corresponding to X135 is a basic residue;
the residue corresponding to X144 is a non-polar, or aromatic residue;
the residue corresponding to X147 is a non-polar, or aliphatic residue;
the residue corresponding to X149 is a polar residue;
the residue corresponding to X153 is a polar, or aromatic residue;
the residue corresponding to X158 is a non-polar, or aliphatic residue;
the residue corresponding to X175 is a polar residue;
the residue corresponding to X190 is an aromatic, aliphatic, non-polar, or polar residue;
the residue corresponding to X196 is an aromatic, polar, basic, non-polar, or aliphatic residue;
the residue corresponding to X197 is an aromatic residue;
the residue corresponding to X198 is a non-polar, polar residue;
the residue corresponding to X201 is a polar residue;
the residue corresponding to X202 is an aromatic, or basic residue;
the residue corresponding to X203 is an aromatic, non-polar, or aliphatic residue;
the residue corresponding to X205 is a polar residue;
the residue corresponding to X206 is an aromatic residue;
the residue corresponding to X207 is an aromatic, acidic, non-polar, or aliphatic residue;
the residue corresponding to X209 is an aromatic, acidic, non-polar, polar, or aliphatic residue;
the residue corresponding to X210 is a non-polar, or aliphatic residue;
the residue corresponding to X212 is an aromatic, basic, non-polar, aliphatic, or acidic residue;
the residue corresponding to X213 is an aromatic, basic, acidic, polar, non-polar, or aliphatic residue;
the residue corresponding to X217 is a polar, or aromatic residue;
the residue corresponding to X233 is a polar residue;
the residue corresponding to X250 is a non-polar residue; and
the residue corresponding to X252 is an aromatic residue.

### Claim 3 (depends on 1)

The engineered polynucleotide encoding the engineered polypeptide of claim 1, further comprising at least one substitution selected from X68V, X94G/Q, X102D, X110E/W, X114G, X135K, X144G/W, X147L, X149S, X150D/F/P/W, X153H/P/T/V/C, X158V, X175T, X190A/L/Q/T/W, X196H/I/K/N/Q, X1961, X196K/N/Q, X197Y, X198G/S, X201N, X202F/H/R/Y, X203G/L/W, X205T, X206H/W/Y, X207D/G/V/Y, X209E/F/G/I/M/T/V/W, X210L/P, X211H/I/P/S, X212A/E/G/H/N/P/R/V, X213D/E/G/H/K/M/N/R, X217H/N, X233Q/T, X250G, and X252W.

### Claim 4 (depends on 1)

The engineered polynucleotide encoding the engineered polypeptide of claim 1, further comprising a substitution at position X190.

### Claim 5 (depends on 4)

The engineered polynucleotide encoding the engineered polypeptide of claim 4, comprising a substitution at position X190, wherein the substitution is selected from P, A, T, or Q.

### Claim 6 (depends on 1)

The engineered polynucleotide encoding the engineered polypeptide claim 1, wherein the stereoselective activity of the polypeptide is increased at least 2-fold as compared to the corresponding activity of the reference polypeptide of SEQ ID NOS: 4, 10, 26, and/or 42.

### Claim 7 (depends on 1)

The engineered polynucleotide of claim 1, in which the polynucleotide comprises a nucleic acid sequence selected from the group consisting of the odd-numbered sequence identifiers of SEQ ID NOS:5-237.

### Claim 8 (depends on 1)

An expression vector comprising the polynucleotide of claim 1.

### Claim 9 (depends on 1)

A host cell comprising the polynucleotide of claim 1.

### Claim 10 (depends on 8)

A host cell comprising the expression vector of claim 8.

### Claim 11 (depends on 9)

The host cell of claim 9, wherein said host cell is E. coli.

### Claim 12 (depends on 10)

The host cell of claim 10, wherein said host cell is E. coli.
